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Abstract. Necrotizing pancreatitis is a serious condition that 
is associated with high morbidity and mortality. Although 
vasospasm is reportedly involved in necrotizing pancreatitis, 
the underlying mechanism is not completely clear. In addition, 
the local renin-angiotensin system has been hypothesized to 
be involved in the progression of pancreatitis and trypsin has 
been shown to generate angiotensin II under weakly acidic 
conditions. However, to the best of our knowledge, no studies 
have reported elevated angiotensin II levels in tissue with 
pancreatitis. In the present study, the concentration of pancre-
atic angiotensin II in rats with experimentally induced acute 
pancreatitis was measured. Acute pancreatitis was induced 
by retrograde injection of 6% sodium taurocholate into the 
biliopancreatic duct. Control rats were sacrificed without 
injection into the biliopancreatic duct. The concentration of 
tissue angiotensin II was measured using the florisil method. 
Angiotensin II concentration in tissues with acute pancreatitis 
measured at 3, 6, 12 and 24 h following taurocholate injection 
were significantly higher than that of normal pancreatic tissue. 
In addition, the concentration of angiotensin II increased in 
a time-dependent manner. The results demonstrated that the 
angiotensin II generating system is involved in the transition 
from edematous to necrotizing pancreatitis in experimental 
animals. We hypothesize that locally formed angiotensin II 
affects the microenvironment in pancreatitis.
Introduction
Acute pancreatitis, particularly the necrotizing type, is 
associated with high morbidity and mortality. Necrotizing 
pancreatitis is characterized by parenchymal non-enhance-
ment on contrast-enhanced computed tomography images (1). 
Although necrosis is irreversible, certain patients exhibiting 
this pancreatic parenchymal non-enhancement recover 
with normal pancreatic conditions (2). Vasospasm has been 
implicated in the development of pancreatic ischemia and 
necrosis (3); however, the precise underlying mechanism is 
unclear.
The local pancreatic renin-angiotensin system (RAS) 
may be a significant etiological factor of pancreatitis (4-9). 
Angiotensin II receptors have been detected in the endothe-
lium of blood vessels and the epithelium of the pancreatic 
ductal system (8). Previous studies have revealed that experi-
mental pancreatitis upregulates the RAS components in the 
pancreas (10,11). However, elevated local angiotensin II levels 
in pancreatitis tissues have not been reported. Trypsin may 
directly induce the generation of the pressor angiotensin II 
from angiotensinogen at a weakly acidic pH, independent of 
the action of angiotensin-converting enzyme (12,13).
In the present study, pancreatic angiotensin II concentra-
tion was measured in experimental animals with pancreatitis 
to evaluate the involvement of the local angiotensin II gener-
ating system in acute pancreatitis.
Materials and methods
Animal and experimental acute pancreatitis model. The 
present study was conducted in compliance with the Division 
for Animal Research Resources, Institute of Kanazawa 
University. The experiments and procedures were approved 
by the Animal Care and Use Committee of the Kanazawa 
University (Ishikawa, Japan).
Male Wistar rats (weight, 250-350 g) were maintained on 
a 12-h light/dark cycle at an ambient temperature of 23˚C. 
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The rats were fasted with free access to water for 12 h prior to 
surgery. Rats were anesthetized with diethyl ether inhalation 
and laparotomy was performed using a midline abdominal 
incision. Acute pancreatitis was induced by retrograde 
injection of 6% sodium taurocholate (Wako Pure Chemical 
Industries, Osaka, Japan) into the biliopancreatic duct at a 
dose of 0.4 ml/kg body weight to induce acute pancreatitis. 
Time 0 indicates the time of injection of sodium taurocholate. 
The rats were divided into groups and sacrificed at 3, 6, 12, 24 
or 36 h following the induction of acute pancreatitis. Control 
rats were sacrificed without injection into the biliopancreatic 
duct.
Sample collection and preparation. Blood samples were 
collected by cardiac puncture for the measurement of plasma 
amylase levels. Pancreatic tissue samples were fixed in 10% 
neutral‑buffered formalin and embedded in paraffin for histo-
logical examination. Parallel samples of pancreatic tissue were 
prepared for the measurement of angiotensin II concentration 
by immediately freezing in liquid nitrogen, followed by storage 
at -80˚C until the time of assay. 
Measurements of angiotensin II in tissues. Frozen tissue 
samples were homogenized at 4˚C in saline containing 0.1% 
NHCl and 5% urinastatin. The homogenate was centrifuged at 
10,000 x g for 30 min at 4˚C and the supernatant was collected 
for radioimmunoassay of angiotensin II using the florisil 
method, as described previously (14).
Statistical analysis. Data were analyzed using the Welch's 
t-test. P<0.05 was considered to indicate a statistically signifi-
cant difference.
Results
Plasma amylase levels. Plasma amylase levels were measured 
to confirm the successful induction of acute pancreatitis. 
Following this induction, plasma amylase levels were 
elevated (Fig. 1).
Histological examination. In the early stages of pancreatitis, 
histological examination indicated subcapsular and interlob-
ular edema, slight inflammatory neutrophilic infiltration and 
a small number of intralobular necrotic lesions. The extent of 
inflammatory cell infiltration and areas of necrosis progressed 
with time. At 24 h following taurocholate injection, marked 
inflammatory and necrotic changes were noted (Fig. 2A‑E). In 
addition, intravenous thromboses were observed, but there was 
no evidence of arterial thrombosis (Fig. 2F).
Angiotensin II concentration in experimental pancreatitis 
tissue. Angiotensin II concentration was measured in pancre-
atic tissue samples obtained at 3, 6, 12, 24 and 36 h following 
taurocholate injection. Up to 24 h, the angiotensin II concentra-
tion was significantly higher in rats with taurocholate‑induced 
pancreatitis compared with controls and the enzyme levels 
were found to increase in a time-dependent manner. However, 
the angiotensin II concentration in pancreatitis tissue at 36 h 
following taurocholate injection was lower than that in pancre-
atitis tissue at 24 h following injection (Fig. 3).
Discussion
Premature activation of trypsin within pancreatic acinar cells 
by various proteases, which in turn are activated by ectopic 
activation of trypsinogen, is hypothesized to represent the 
main etiological factor in pancreatitis. A number of studies in 
acute pancreatitis have examined the mechanisms by which 
edematous injury progresses to necrosis. In experimental 
models, pancreatic vascular perfusion failure has been impli-
cated in the development of pancreatitis. Spormann et al (15) 
demonstrated that temporary ischemia significantly augmented 
the severity of pathology and Klar et al (16) revealed that 
vasoconstrictor administration has adverse effects in experi-
mental acute pancreatitis. Intravascular thromboses have been 
indicated to represent a significant factor (17). Although intra-
venous thromboses were noted in the present study, arterial 
thromboses were not observed.
Deterioration of the balance between nitric oxide and 
endothelins has also been hypothesized to account for the 
development of necrotizing pancreatitis (18,19); however, the 
association between this abnormal balance and trypsin, the 
key molecule in the etiology of pancreatitis, is unclear.
It has been hypothesized that an intrinsic tissue RAS may 
be present in the pancreas (4). Chan et al (20) have demon-
strated activation of the pancreatic RAS in a rat model of 
chronic hypoxia. Leung et al (10) revealed that experimental 
pancreatitis induced upregulation of several key RAS compo-
nents in the pancreas. Several other studies have reported that 
RAS blockers are effective in the treatment of experimental 
pancreatitis (21-23).
Hypovascularity is a key characteristic of not only 
necrotizing pancreatitis but also pancreatic ductal cancer. 
The majority of pancreatic ductal cancers are hypovascular 
or avascular on angiography, but the angiography of surgi-
cally resected specimens cannot always accurately confirm 
poor circulation. Figarella et al (24) reported that cationic 
trypsinogen is spontaneously converted to trypsin under 
acidic conditions and Tajima et al (25) demonstrated that 
tumor-derived trypsin, activated by acidic conditions, was a 
key factor in tumor invasion. Ohta et al (26) found that angio-
tensin II acts on the pre-existing pancreatic arteries around the 
tumor leading to formation of hypovascular regions. Since the 
microenvironment around the tumor cells is more acidic than 
Figure 1. Plasma amylase levels in rats with taurocholate-induced pancre-
atitis were significantly higher than those of the control (*P<0.05). Data are 
presented as the mean ± SD.
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that of the majority of normal tissues, this phenomenon may 
be associated with tumor-derived trypsin, directly generating 
angiotensin II from angiotensinogen (27,28).
It was reported that the pH of the inflammatory exudate 
decreases with time (29-31) due to local acid production by 
glycolytic infiltrating neutrophils and low oxygen tension in 
inflammatory lesions. In the early phase of pancreatitis devel-
opment, the depressor, bradykinin, was produced at a weakly 
alkaline pH. Therefore, pancreatic hyperemia and edema 
were observed. With time, the inflammation progressed, pH 
decreased and angiotensin II was produced under weakly 
acidic conditions by trypsin. In addition, pancreatic ischemia 
and necrosis were observed (Fig. 4). In our model of experi-
mental pancreatitis, angiotensin II concentration decreased 
Figure 2. Histological examination of rat pancreatic tissue in taurocholate-induced pancreatitis. (A) Control, (B) 3, (C) 6, (D) 12 and (E) 24 h following 
taurocholate injection (H&E stain; magnification, x100; bar length, 250 µm). Histopathological sections reveal (A) subcapsular and interlobular edema, slight 
inflammatory cell infiltration and (B) a small number of intralobular necrotic lesions; (C and D) inflammatory cell infiltration and areas of necrosis progressed 
in a time-dependent manner and (E) a large amount of necrosis and hemorrhage was observed. (F) Intravenous thromboses were observed (arrowheads), but 
arterial thrombosis was not noted. H&E, hematoxylin and eosin.
Figure 3. Pancreatic angiotensin II concentrations in rats with taurocho-
late-induced pancreatitis. Angiotensin II concentration was 151.2±58.5 pg/g 
wet tissue in control pancreatic tissue and 225.5±43.9, 270±118.6, 414.5±156.9 
and 464.4±192.9 pg/g wet tissue in pancreatic tissue at 3, 6, 12 and 24 h 
following injection of taurocholate, respectively. Tissue angiotensin II 
concentrations in pancreatitis at 3, 6, 12 and 24 h following injection were 
significantly higher than that in control pancreatic tissue (*P<0.05). The con-
centration of angiotensin II in pancreatitis tissue at 36 h following injection 
was 182.4±72.1 pg/g, lower than that at 24 h following injection. Each point 
represents the value and each bar represents the mean ± SD.
Figure 4. Proposed mechanism of the trypsin-related and cathepsin G-related 
angiotensin II generating system, and evolution of edematous pancreatitis 
into necrotizing pancreatitis. In the early phases of pancreatitis, the depressor 
bradykinin, is produced from kininogen by trypsin at a weakly alkaline 
pH. Thereafter, pancreatic hyperemia and edema develop (edematous pan-
creatitis). Inflammation progresses with time, as the pH decreases. Pressor 
angiotensin II is produced from angiotensinogen at a weakly acidic pH. 
Similarly, the inflammation progresses with time, as neutrophils infiltrate. 
Angiotensin II is produced by cathepsin G released by infiltrating neutrophils 
and pancreatic ischemia and necrosis develop (necrotizing pancreatitis).
  A   B   C
  D   E   F
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at 36 h, as compared with that at 24 h. We hypothesize that 
pancreatic tissue destruction may be responsible for the degra-
dation of angiotensin II.
Cathepsin G, one of the serine proteinases expressed in 
the azurophilic granules of neutrophils, has the potential to 
induce angiotensin II production (32). In the early phases of 
acute pancreatitis, the presence of subcapsular and intralob-
ular edema, slight neutrophil infiltration and a small number 
of intralobular necrotic lesions were noted. The extent of 
neutrophil infiltration and areas of necrosis progressed over 
time. Cathepsin G released by infiltrating neutrophils may 
be involved in angiotensin II generation (33). As the inflam-
mation progressed with time, angiotensin II was produced 
by cathepsin G released by infiltrating neutrophils (Fig. 4). A 
number of studies have reported that the neutrophil elastase 
inhibitor prevents neutrophil infiltration into the extravascular 
tissue (34,35). Although there are no cathepsin G inhibitors 
available for clinical use today, the neutrophil elastase inhibitor 
may suppress the angiotensin II generated by the cathepsin G 
released by infiltrating neutrophils.
In conclusion, the present study indicates that angio-
tensin II generation is instrumental in the transition from 
experimental edematous pancreatitis to necrotizing pancre-
atitis. We hypothesize that locally formed angiotensin II may 
act on the pancreatic arteries leading to regional hypovascu-
larity. Therefore, inhibition of the angiotensin II generating 
system by administration of angiotensin receptor blockers, 
serine protease inhibitors or elastase inhibitors may be useful 
for preventing the evolution of edematous pancre atitis into 
necrotizing pancreatitis.
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